# Selective Insurance Group Inc: overview

SIGI · Nasdaq · CIK 230557 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sigi.md) · [Financials](/companies/sigi/financials.md) · [Filings](/companies/sigi/filings.md) · [Insiders](/companies/sigi/insiders.md)

Latest reported revenue: [$1.33bn](/filings/0000230557-26-000027.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 23, 2026 (XBRL us-gaap:Revenues, accession 0000230557-26-000027).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,256 d](/filings/0000230557-26-000006.md) | [1,285](/filings/0000230557-26-000011.md) | [1,327](/filings/0000230557-26-000020.md) | [1,360](/filings/0000230557-26-000027.md) | [1,365 d](/filings/0000230557-26-000006.md) | [1,359](/filings/0000230557-26-000011.md) | [1,387](/filings/0000230557-26-000020.md) | [1,326](/filings/0000230557-26-000027.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [7.6% d](/filings/0000230557-26-000006.md) | [8.6%](/filings/0000230557-26-000011.md) | [6.5%](/filings/0000230557-26-000020.md) | [8.5%](/filings/0000230557-26-000027.md) | [11.4% d](/filings/0000230557-26-000006.md) | [7.2%](/filings/0000230557-26-000011.md) | [9.3%](/filings/0000230557-26-000020.md) | [9.7%](/filings/0000230557-26-000027.md) |
| Diluted EPS | $ per share | not reported | [1.76](/filings/0000230557-26-000011.md) | [1.36](/filings/0000230557-26-000020.md) | [1.85](/filings/0000230557-26-000027.md) | not reported | [1.58](/filings/0000230557-26-000011.md) | [2.11](/filings/0000230557-26-000020.md) | [2.11](/filings/0000230557-26-000027.md) |
| Free cash flow | $m | [325 d](/filings/0000230557-26-000006.md) | [271](/filings/0000230557-26-000011.md) | [160 d](/filings/0000230557-26-000020.md) | [397 d](/filings/0000230557-26-000027.md) | [366 d](/filings/0000230557-26-000006.md) | [211](/filings/0000230557-26-000011.md) | [215 d](/filings/0000230557-26-000020.md) | [347 d](/filings/0000230557-26-000027.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,379](/filings/0000230557-24-000005.md) | [3,558](/filings/0000230557-25-000006.md) | [4,232](/filings/0000230557-26-000006.md) | [4,862](/filings/0000230557-26-000006.md) | [5,337](/filings/0000230557-26-000006.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [12.0%](/filings/0000230557-24-000005.md) | [6.3%](/filings/0000230557-25-000006.md) | [8.6%](/filings/0000230557-26-000006.md) | [4.3%](/filings/0000230557-26-000006.md) | [8.7%](/filings/0000230557-26-000006.md) |
| Diluted EPS | $ per share | [6.50](/filings/0000230557-24-000005.md) | [3.54](/filings/0000230557-25-000006.md) | [5.84](/filings/0000230557-26-000006.md) | [3.23](/filings/0000230557-26-000006.md) | [7.49](/filings/0000230557-26-000006.md) |
| Free cash flow | $m | [749](/filings/0000230557-24-000005.md) | [776](/filings/0000230557-25-000006.md) | [736](/filings/0000230557-26-000006.md) | [1,069](/filings/0000230557-26-000006.md) | [1,194](/filings/0000230557-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sigi/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-26 | [Nicholson Cynthia S](/insiders/1470648.md) | Director | Sale (S) | 3,691 | $98.711 | $364.3k | [Form 4](/filings/0001225208-26-008499.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $754.6m | 7,778,138 |  | Added +278,988 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $339.1m | 3,495,978 |  | Added +36,728 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $324.5m | 3,345,130 |  | Reduced −591,528 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $261.7m | 2,697,663 |  | Added +15,202 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $237.8m | 2,451,382 |  | Added +125,102 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $216.2m | 2,228,969 |  | Added +961,697 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $188.4m | 1,941,671 |  | Reduced −559,560 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $177.1m | 1,825,150 |  | Added +116,331 |
| [FIRST TRUST ADVISORS LP](/funds/1125816.md) | 2026-06-30 | $156.2m | 1,610,141 |  | Added +228,274 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $140.6m | 1,449,582 |  | Added +90,358 |

## Recent filings

[All 1,294 filings](/companies/sigi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 13:40 ET | [10-Q](/filings/0000230557-26-000027.md) | Quarterly report, period 2026-09-30 | 0000230557-26-000027 |
| 2026-10-22 | 16:18 ET | [8-K](/filings/0000230557-26-000024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000230557-26-000024 |
| 2026-09-16 | 16:20 ET | [8-K](/filings/0001104659-26-108267.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-108267 |
| 2026-07-24 | 14:18 ET | [10-Q](/filings/0000230557-26-000020.md) | Quarterly report, period 2026-06-30 | 0000230557-26-000020 |
| 2026-07-23 | 16:18 ET | [8-K](/filings/0000230557-26-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000230557-26-000018 |
| 2026-05-14 | 16:01 ET | [8-K](/filings/0001104659-26-061133.md) | 5.02 Departure or appointment of officers or directors | 0001104659-26-061133 |
| 2026-04-30 | 09:40 ET | [8-K](/filings/0000230557-26-000013.md) | 5.07 Shareholder vote results | 0000230557-26-000013 |
| 2026-04-24 | 13:50 ET | [10-Q](/filings/0000230557-26-000011.md) | Quarterly report, period 2026-03-31 | 0000230557-26-000011 |
| 2026-04-22 | 16:18 ET | [8-K](/filings/0000230557-26-000008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000230557-26-000008 |
| 2026-03-26 | 09:46 ET | [DEF 14A](/filings/0001104659-26-034953.md) | Proxy statement, period 2026-04-29 | 0001104659-26-034953 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000230557-26-000006.md), filed Feb 9, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 230557
- Tickers: SIGI, SIGIP
- Exchange: Nasdaq
- SIC code: 6331 Fire, Marine & Casualty Insurance
- State of incorporation: NJ
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:12 ET. No prices; not investment advice.